Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Non-Current Assets: 2013-2024

Historic Other Non-Current Assets for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to $3.3 million.

  • Fortress Biotech's Other Non-Current Assets rose 440.57% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 440.57%. This contributed to the annual value of $3.3 million for FY2024, which is 22.60% down from last year.
  • Fortress Biotech's Other Non-Current Assets amounted to $3.3 million in FY2024, which was down 22.60% from $4.3 million recorded in FY2023.
  • Fortress Biotech's 5-year Other Non-Current Assets high stood at $4.3 million for FY2023, and its period low was $1.6 million during FY2020.
  • Its 3-year average for Other Non-Current Assets is $3.4 million, with a median of $3.3 million in 2024.
  • Per our database at Business Quant, Fortress Biotech's Other Non-Current Assets slumped by 90.09% in 2020 and then spiked by 59.38% in 2023.
  • Fortress Biotech's Other Non-Current Assets (Yearly) stood at $1.6 million in 2020, then surged by 34.95% to $2.2 million in 2021, then rose by 21.08% to $2.7 million in 2022, then surged by 59.38% to $4.3 million in 2023, then decreased by 22.60% to $3.3 million in 2024.